• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗接种途径改变抗原转运,但不改变固有或适应性免疫。

Route of Vaccine Administration Alters Antigen Trafficking but Not Innate or Adaptive Immunity.

机构信息

Department of Medicine Solna, Division of Immunology and Allergy, Karolinska Institutet and University Hospital, 171 64 Stockholm, Sweden; Center for Molecular Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden.

IAVI Neutralizing Antibody Center, Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.

出版信息

Cell Rep. 2020 Mar 24;30(12):3964-3971.e7. doi: 10.1016/j.celrep.2020.02.111.

DOI:10.1016/j.celrep.2020.02.111
PMID:32209459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7198771/
Abstract

Although intramuscular (i.m.) administration is the most commonly used route for licensed vaccines, subcutaneous (s.c.) delivery is being explored for several new vaccines under development. Here, we use rhesus macaques, physiologically relevant to humans, to identify the anatomical compartments and early immune processes engaged in the response to immunization via the two routes. Administration of fluorescently labeled HIV-1 envelope glycoprotein trimers displayed on liposomes enables visualization of targeted cells and tissues. Both s.c. and i.m. routes induce efficient immune cell infiltration, activation, and antigen uptake, functions that are tightly restricted to the skin and muscle, respectively. Antigen is also transported to different lymph nodes depending on route. However, these early differences do not translate into significant differences in the magnitude or quality of antigen-specific cellular and humoral responses over time. Thus, although some distinct immunological differences are noted, the choice of route may instead be motivated by clinical practicality.

摘要

虽然肌肉内(i.m.)给药是已获许可疫苗最常使用的途径,但皮下(s.c.)给药正在被探索用于几种新开发的疫苗。在这里,我们使用与人类生理相关的恒河猴来确定用于免疫接种的两种途径所涉及的解剖隔室和早期免疫过程。通过荧光标记的脂质体展示 HIV-1 包膜糖蛋白三聚体的给药使靶向细胞和组织的可视化成为可能。皮下和肌肉内途径均可诱导有效的免疫细胞浸润、激活和抗原摄取,这些功能分别受到皮肤和肌肉的严格限制。根据途径的不同,抗原也会被运送到不同的淋巴结。然而,这些早期差异并没有转化为随着时间的推移,抗原特异性细胞和体液反应的数量或质量的显著差异。因此,尽管观察到了一些明显的免疫学差异,但选择途径的依据可能更多的是临床实用性。

相似文献

1
Route of Vaccine Administration Alters Antigen Trafficking but Not Innate or Adaptive Immunity.疫苗接种途径改变抗原转运,但不改变固有或适应性免疫。
Cell Rep. 2020 Mar 24;30(12):3964-3971.e7. doi: 10.1016/j.celrep.2020.02.111.
2
Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake.疫苗启动仅限于引流淋巴结,并受佐剂介导的抗原摄取所控制。
Sci Transl Med. 2017 Jun 7;9(393). doi: 10.1126/scitranslmed.aal2094.
3
Routing dependent immune responses after experimental R848-adjuvated vaccination.实验性 R848 佐剂疫苗接种后的路由依赖免疫反应。
Vaccine. 2018 Mar 7;36(11):1405-1413. doi: 10.1016/j.vaccine.2018.01.077.
4
DNA-MVA-protein vaccination of rhesus macaques induces HIV-specific immunity in mucosal-associated lymph nodes and functional antibodies.恒河猴的DNA-MVA-蛋白质疫苗接种可在黏膜相关淋巴结中诱导HIV特异性免疫和功能性抗体。
Vaccine. 2017 Feb 7;35(6):929-937. doi: 10.1016/j.vaccine.2016.12.060. Epub 2017 Jan 6.
5
Mucosal model of genital immunization in male rhesus macaques with a recombinant simian immunodeficiency virus p27 antigen.用重组猿猴免疫缺陷病毒p27抗原对雄性恒河猴进行生殖器免疫的黏膜模型。
J Virol. 1994 Mar;68(3):1624-32. doi: 10.1128/JVI.68.3.1624-1632.1994.
6
Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site.在接种CD4受体结合位点被封闭的gp140的猕猴中,与针对HIV-1包膜的辅助性T细胞反应相关的增强、持久的B细胞和ADCC反应。
J Virol. 2017 Sep 12;91(19). doi: 10.1128/JVI.00811-17. Print 2017 Oct 1.
7
Early T Follicular Helper Cell Responses and Germinal Center Reactions Are Associated with Viremia Control in Immunized Rhesus Macaques.早期 T 滤泡辅助细胞反应和生发中心反应与免疫恒河猴的病毒血症控制相关。
J Virol. 2019 Feb 5;93(4). doi: 10.1128/JVI.01687-18. Print 2019 Feb 15.
8
Primate immune responses to HIV-1 Env formulated in the saponin-based adjuvant AbISCO-100 in the presence or absence of TLR9 co-stimulation.在存在或不存在TLR9共刺激的情况下,灵长类动物对基于皂苷的佐剂AbISCO-100配制的HIV-1 Env的免疫反应。
Sci Rep. 2015 Mar 12;5:8925. doi: 10.1038/srep08925.
9
Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses.在恒河猴中,将HIV-1包膜糖蛋白gp140靶向CD40与靶向凝集素样氧化低密度脂蛋白受体1(LOX-1)相比,并结合具有复制能力的NYVAC-KC,在诱导Env特异性抗体和T细胞反应方面的优势。
J Virol. 2017 Apr 13;91(9). doi: 10.1128/JVI.01596-16. Print 2017 May 1.
10
Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques.恒河猴经修饰 mRNA 疫苗给药后体内抗原呈递细胞的有效靶向和激活。
Mol Ther. 2017 Dec 6;25(12):2635-2647. doi: 10.1016/j.ymthe.2017.08.006. Epub 2017 Aug 12.

引用本文的文献

1
Vaccination with an mRNA-encoded membrane-bound HIV envelope trimer induces neutralizing antibodies in animal models.用mRNA编码的膜结合HIV包膜三聚体进行疫苗接种可在动物模型中诱导中和抗体。
Sci Transl Med. 2025 Jul 30;17(809):eadw0721. doi: 10.1126/scitranslmed.adw0721.
2
Advances in the Functionalization of Vaccine Delivery Systems: Innovative Strategies and Translational Perspectives.疫苗递送系统功能化的进展:创新策略与转化前景
Pharmaceutics. 2025 May 12;17(5):640. doi: 10.3390/pharmaceutics17050640.
3
Re-adenylation by TENT5A enhances efficacy of SARS-CoV-2 mRNA vaccines.

本文引用的文献

1
Visualization of early events in mRNA vaccine delivery in non-human primates via PET-CT and near-infrared imaging.通过 PET-CT 和近红外成像技术可视化非人灵长类动物 mRNA 疫苗传递的早期事件。
Nat Biomed Eng. 2019 May;3(5):371-380. doi: 10.1038/s41551-019-0378-3. Epub 2019 Apr 1.
2
Structure-Guided Redesign Improves NFL HIV Env Trimer Integrity and Identifies an Inter-Protomer Disulfide Permitting Post-Expression Cleavage.基于结构的重新设计改善了NFL HIV包膜三聚体的完整性,并确定了一个允许表达后切割的亚基间二硫键。
Front Immunol. 2018 Jul 17;9:1631. doi: 10.3389/fimmu.2018.01631. eCollection 2018.
3
Evans Blue Dye: A Revisit of Its Applications in Biomedicine.
TENT5A进行的再腺苷酸化增强了SARS-CoV-2 mRNA疫苗的效力。
Nature. 2025 May;641(8064):984-992. doi: 10.1038/s41586-025-08842-1. Epub 2025 Apr 16.
4
Diverse priming outcomes under conditions of very rare precursor B cells.在极罕见的前体B细胞条件下的多种启动结果。
Immunity. 2025 Apr 8;58(4):997-1014.e11. doi: 10.1016/j.immuni.2025.03.003. Epub 2025 Mar 31.
5
Monitoring mRNA vaccine antigen expression in vivo using PET/CT.使用正电子发射断层扫描/计算机断层扫描(PET/CT)在体内监测mRNA疫苗抗原表达。
Nat Commun. 2025 Mar 6;16(1):2234. doi: 10.1038/s41467-025-57446-w.
6
The saponin monophosphoryl lipid A nanoparticle adjuvant induces dose-dependent HIV vaccine responses in nonhuman primates.皂苷单磷酰脂质A纳米颗粒佐剂在非人灵长类动物中诱导出剂量依赖性的HIV疫苗反应。
J Clin Invest. 2025 Mar 4;135(8). doi: 10.1172/JCI185292. eCollection 2025 Apr 15.
7
Therapeutic Vaccines for Hematological Cancers: A Scoping Review of This Immunotherapeutic Approach as Alternative to the Treatment of These Malignancies.血液系统恶性肿瘤的治疗性疫苗:作为这些恶性肿瘤治疗替代方法的这种免疫治疗方法的范围综述
Vaccines (Basel). 2025 Jan 23;13(2):114. doi: 10.3390/vaccines13020114.
8
An LNP-mRNA vaccine modulates innate cell trafficking and promotes polyfunctional Th1 CD4 T cell responses to enhance BCG-induced protective immunity against Mycobacterium tuberculosis.脂质纳米颗粒-信使核糖核酸疫苗可调节天然细胞转运,并促进多功能辅助性T1型CD4 T细胞反应,以增强卡介苗诱导的针对结核分枝杆菌的保护性免疫。
EBioMedicine. 2025 Mar;113:105599. doi: 10.1016/j.ebiom.2025.105599. Epub 2025 Feb 15.
9
Off-The-Shelf Multivalent Nanoconjugate Cancer Vaccine Rescues Host Immune Response against Melanoma.现成的多价纳米缀合物癌症疫苗可挽救宿主针对黑色素瘤的免疫反应。
Adv Mater. 2025 Apr;37(16):e2417348. doi: 10.1002/adma.202417348. Epub 2025 Feb 12.
10
Small circular RNAs as vaccines for cancer immunotherapy.作为癌症免疫疗法疫苗的小环状RNA
Nat Biomed Eng. 2025 Feb;9(2):249-267. doi: 10.1038/s41551-025-01344-5. Epub 2025 Feb 7.
埃文斯蓝染料:在生物医学中的再应用。
Contrast Media Mol Imaging. 2018 Apr 22;2018:7628037. doi: 10.1155/2018/7628037. eCollection 2018.
4
TLR-adjuvanted nanoparticle vaccines differentially influence the quality and longevity of responses to malaria antigen Pfs25.TLR 佐剂纳米颗粒疫苗对疟疾抗原 Pfs25 应答的质量和持久性有不同影响。
JCI Insight. 2018 May 17;3(10). doi: 10.1172/jci.insight.120692.
5
Induction of Robust B Cell Responses after Influenza mRNA Vaccination Is Accompanied by Circulating Hemagglutinin-Specific ICOS+ PD-1+ CXCR3+ T Follicular Helper Cells.流感mRNA疫苗接种后诱导强烈的B细胞反应伴随着循环中血凝素特异性ICOS+ PD-1+ CXCR3+滤泡辅助性T细胞。
Front Immunol. 2017 Nov 13;8:1539. doi: 10.3389/fimmu.2017.01539. eCollection 2017.
6
Beyond binding: antibody effector functions in infectious diseases.超越结合:传染病中的抗体效应功能。
Nat Rev Immunol. 2018 Jan;18(1):46-61. doi: 10.1038/nri.2017.106. Epub 2017 Oct 24.
7
Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques.恒河猴经修饰 mRNA 疫苗给药后体内抗原呈递细胞的有效靶向和激活。
Mol Ther. 2017 Dec 6;25(12):2635-2647. doi: 10.1016/j.ymthe.2017.08.006. Epub 2017 Aug 12.
8
Non-human primates as a model for understanding the mechanism of action of toll-like receptor-based vaccine adjuvants.非人灵长类动物作为一种模型,用于理解 Toll 样受体为基础的疫苗佐剂的作用机制。
Curr Opin Immunol. 2017 Aug;47:1-7. doi: 10.1016/j.coi.2017.06.006. Epub 2017 Jul 15.
9
Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches.使用优化方法通过HIV包膜三聚体免疫在非人灵长类动物中引发强大的二级中和抗体反应。
Immunity. 2017 Jun 20;46(6):1073-1088.e6. doi: 10.1016/j.immuni.2017.05.007.
10
Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake.疫苗启动仅限于引流淋巴结,并受佐剂介导的抗原摄取所控制。
Sci Transl Med. 2017 Jun 7;9(393). doi: 10.1126/scitranslmed.aal2094.